Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

SOD1 (EDI) Antibody: ATTO 594

Product Sizes
100 ug
£481.00
SPC-206D-A594-100UG
About this Product
SKU:
SPC-206D-A594
Additional Names:
SOD1, Superoxide dismutase [Cu-Zn], Cu/Zn superoxide dismutase, SODC_HUMAN, ALS1, SOD1 EDI, SEDI, SOD1 exposed dimer interface, Conformationally altered SOD1, Misfolded SOD1, Apo-SOD1, Superoxide dismutase 1, SOD
Application:
ELISA, Immunohistochemistry, Western Blot
Buffer:
640.91mM DMSO, 136.36 mM Ethanolamine, 126.89 mM chlorides, 9.09mM phosphates, 9.09mM NaHCO3
CE/IVD:
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
Clonality:
Polyclonal
Conjugate:
ATTO 594
Concentration:
1 mg/ml
Extra Details:
Superoxide dismutase 1 (SOD1) is a cytosolic antioxidant enzyme that catalyzes the dismutation of superoxide radicals (O₂-) into hydrogen peroxide (H₂O₂) and molecular oxygen (O₂), playing a vital role in cellular redox homeostasis. Structurally, SOD1 is a 32 kDa homodimer, with each 16 kDa subunit stabilized by copper and zinc ions, an intra-subunit disulfide bridge, and a tightly packed B Beta-barrel fold. In neurodegenerative disease research-particularly amyotrophic lateral sclerosis (ALS)-SOD1 misfolding and aggregation are key pathological features. One critical conformational change involves the exposure of the dimer interface (EDI), a normally buried region essential for SOD1 stability and enzymatic function. This structural disruption is associated with toxic gain-of-function mechanisms and neuronal degeneration. Conformation-specific antibodies such as SOD1 (EDI) are designed to selectively recognize this exposed dimer interface, enabling researchers to detect early misfolding events in ALS-affected tissues. When used in combination with antibodies like SOD1 (UB BetaB) (catalog# SPC-205), which targets the unfolded B Beta-barrel region, these tools provide a powerful means of mapping SOD1 conformational states and tracking disease progression. Targeting the exposed dimer interface of SOD1 offers a promising strategy for understanding ALS pathogenesis and developing precision diagnostics and therapeutics in neurodegenerative disease research.
Host:
Rabbit
Immunogen:
C-terminal region of human SOD1, exposed dimer interface (EDI)
Purification:
Protein A Purified
Reactivities:
Human, Mouse, Porcine, Rat
Shipping Conditions:
Blue Ice
Specificity:
Recognizes a conformation specific epitope where the dimer interface is exposed.
Storage Conditions:
See Manual
Supplier:
StressMarq Biosciences
Type:
Antibody: Polyclonal Antibody